Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
Condition(s) studied
Study summary
Myositis are rare diseases for which the development of a cohort associated with a bank of biological samples (biobank) will allow for the conduct of researches to better delineate the underlying pathophysiology and find cures. This prospective cohort of patients with myositis will allow for identification of factors favouring the occurrence of myositis, whether they are constitutional (genetic) or acquired (environmental or drug). Different subgroups of myositis used for prognostication will be identified based on clinico-demographical variables, the nature of the organs involved beyond peripheral muscles (cardiac, diaphragm) and biomarkers abnormalities
Eligibility
Primary outcome measure(s)
- Characterisation of the different myositis subgroups based on clinical, radiological, electrophysiological and histobiological evaluations — baseline: first 30 days after inclusion
Characterisation of the different myositis subgroups based on clinical, radiological, electrophysiological and histobiological evaluations
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Département de médecine interne et immunolgie clinique, Hôpital Pitié Salpêtrière | Paris | France | Recruiting |
| Département de pharmacologie clinique, Hôpital Pitié Salpêtrière | Paris | France | Recruiting |
More Assistance Publique - Hôpitaux de Paris trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05454527 on ClinicalTrials.gov ↗ ← All trials in France